Dr. Sweet-Cordero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
265 Campus drive
Lorey Lokey Stem Cell Research Building 2078B
Palo Alto, CA 94305- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2002
- University of California (San Francisco)Residency, Pediatrics, 1995 - 1998
- University of California San Francisco School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - 2025
- MA State Medical License 1999 - 2006
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Member, American Society for Clinical Investigation ASCI, 2011
Publications & Presentations
PubMed
- The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies.Kieren Marini, Emma Champion, Alex Lee, Isabelle Young, Stanley Leung, Nicolas Mathey-Andrews, Tyler Jacks, Peter Jackson, Jennifer Cochran, Eric Sweet-Cordero> ;Research Square. 2024 Mar 22
- 14 citationsA comprehensive circulating tumor DNA assay for detection of translocation and copy number changes in pediatric sarcomas, , , , , , , , , , , , , , , , , , , , , > ;Molecular Cancer Therapeutics. 2021 Aug 5
- 6 citationsCharting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Fo...Sarah B. Whittle, Katharine Offer, Ryan D. Roberts, Amy K. LeBlanc, Cheryl A. London, Robbie G. Majzner, Alex Yee-Chen Huang, Peter J. Houghton, E. Alejandro Sweet Cor...> ;Pediatric Blood & Cancer. 2021 Jun 16
- Join now to see all
Grant Support
- Mechanisms Of Chemotherapy Response And Tumor Re-Initiation In Lung CancerNational Cancer Institute2011–2012
- Comparative Functional Genomics For Lung Cancer Gene DiscoveryNational Cancer Institute2008–2011
- Identification Of Novel KRAS Effector Pathways In Lung CancerNational Cancer Institute2009–2010
- Tumor Progression In A Mouse Model Of Lung CancerNational Cancer Institute2005–2007
- Tumor Progression In A Mouse Model Of Lung CancerNational Cancer Institute2003–2004
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: